July 7, 2020 / 5:52 AM / a month ago

BRIEF-Diasorin Launches New Molecular Simplexa Test

July 7 (Reuters) - DiaSorin SpA:

* LAUNCHES NEW SIMPLEXATM FLU A / B & RSV DIRECT GEN II MARKED TEST CE, EXECUTABLE IN COMBINATION WITH SIMPLEXA ™ COVID-19 DIRECT TEST

* MOLECULAR TEST IS ABLE TO IDENTIFY TYPE A AND B FLU STRAINS AND RESPIRATORY SYNCYTIAL VIRUS (RSV) WITHOUT NEED TO PERFORM NUCLEIC ACID EXTRACTION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below